Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007749
Filing Date
2004-03-12
Accepted
2004-03-12 17:23:47
Documents
11
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2130478z10-k.htm 10-K 785028
3 EXHIBIT 10.68 a2130478zex-10_68.htm EX-10.68 78463
4 EXHIBIT 10.69 a2130478zex-10_69.htm EX-10.69 21239
5 EXHIBIT 10.70 a2130478zex-10_70.htm EX-10.70 61657
6 EXHIBIT 10.71 a2130478zex-10_71.htm EX-10.71 61569
7 EXHIBIT 10.72 a2130478zex-10_72.htm EX-10.72 62606
8 EXHIBIT 21.1 a2130478zex-21_1.htm EX-21.1 1113
9 EXHIBIT 23.1 a2130478zex-23_1.htm EX-23.1 2831
10 EXHIBIT 31.1 a2130478zex-31_1.htm EX-31.1 5400
11 EXHIBIT 31.2 a2130478zex-31_2.htm EX-31.2 5538
12 EXHIBIT 32.1 a2130478zex-32_1.htm EX-32.1 3895
  Complete submission text file 0001047469-04-007749.txt   1092142
Mailing Address 3280 BAYSHORE BLVD BRISBANE CA 94005
Business Address 3280 BAYSHORE BLVD BRISBANE CA 94005 415 466 2200
INTERMUNE INC (Filer) CIK: 0001087432 (see all company filings)

EIN.: 943296648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29801 | Film No.: 04667044
SIC: 2834 Pharmaceutical Preparations